Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kassiani Mellou has a total of 492 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Salmonellosis Among Children Aged 0–14 Years in Greece over the Period 2005–2024: Descriptive Analysis of Surveillance Data from the Mandatory Notification System

    by Lida Politi, Theologia Sideroglou, Eleni Triantafyllou, Georgia Mandilara, Anthi Chrysostomou, Kassiani Mellou, Theano Georgakopoulou, Karolina Akinosoglou

    Foodborne diseases remain a major public health challenge. Among them, salmonellosis is one of the most frequently reported illnesses, associated with clusters and outbreaks and with considerable morbidity, potentially severe in vulnerable populations. Children are more susceptible due to biological, behavioral, and dietary factors. This study aimed to summarize and describe national surveillance data from the Mandatory Notification System, combined with serotyping data, on reported salmonellosis cases in Greece during the period 2005–2024, with a focus on children aged 0–14 years. During the study period, a total of 7340 salmonellosis cases were reported among children aged 0–14 years. Notification rates declined gradually until 2021, followed by an increase through 2024. The mean annual notification rate was 23.0 cases per 100,000 population, with the highest incidence observed among children aged 0–4 years. A clear seasonal pattern was observed, with a peak during summer months, alongside notable geographical variation. The most frequently identified serovars were Salmonella Enteritidis and Salmonella Typhimurium. These findings indicate that salmonellosis remains a public health concern in the pediatric population, highlighting the need for enhanced surveillance, improved food hygiene practices, and targeted prevention strategies to reduce disease burden.

  • Open Access

    Public health implications of dog bite injuries in Greece

    by Georgios Dougas, Maria Gkova, Kassiani Mellou


  • Open Access

    Emergence of NDM-1-Producing Pseudomonas aeruginosa Nosocomial Isolates in Attica Region of Greece

    by Olga Pappa, Christina Louka, Kleon Karadimas, Evangelia Maikousi, Angeliki Tzoukmani, Michalis Polemis, Anna-Danai Panopoulou, Ioannis Daniil, Stella Chryssou, Kassiani Mellou, et al.

    Here, we report on the emergence and spread of multidrug-resistant NDM-1-producing P. aeruginosa isolates from patients hospitalized in the Attica region, Greece, in 2022 to provide data on their resistome, their virulome, the genetic environment of blaNDM-1, and their molecular epidemiology. A total of 17 carbapenem-resistant P. aeruginosa isolates identified as NDM-producers by immunochromatography at the hospital level were sent to the Central Public Health Laboratory, in the frame of the laboratory surveillance of carbapenem-resistant pathogens, for further characterization. The initial screening for genetic AMR determinants was carried out by PCR and the MDR Direct Flow Chip assay. Typing was performed by MLST and DLST, the latter in a subset of isolates. Further analysis was performed by whole-genome sequencing (WGS) of six isolates from both hospitals to analyze their entire genomes and elucidate their genetic relatedness. All isolates were allocated to international high-risk clones, sixteen to ST773 and one to ST308. Five ST773 and the sole ST308 isolate were found to harbor the blaNDM-1 gene, along with various other ARGs integrated into their chromosomes, as well as with a wide variety of virulence genes. The blaNDM-1 gene was located in the integrative and conjugative elements ICE6600-like and ICETn43716385 in ST773 and ST308 isolates, respectively. Single-nucleotide polymorphism analysis of the five ST773 isolates indicated their clonal spread in both hospitals. These results suggested that two different molecular events contributed to the emergence of NDM-1-producing P. aeruginosa isolates in Athenian hospitals, highlighting the need for ongoing surveillance.


  • Open Access

    Gastroenteritis Outbreaks after Contamination of Water Supply Systems: Public Health Response Gaps and Challenges, Greece, 2004–2023

    by Theologia Sideroglou, Anthi Chrysostomou, Lida Politi, Leonidas Georgalis, Kassiani Mellou

    Background: waterborne disease outbreaks (WGDOs) following the contamination of drinking water remain a public health concern. Methods: The current study aims to assess the occurrence and identify gaps in the notification and investigation of WGDOs in Greece. Data for 2004–2023 were retrieved and summarized. Results: Thirty-five outbreaks with 6128 recorded cases were identified. The median time from the date of onset in the first cases to reporting was 7 days (range: 1–26 days). Authorities were informed by health care services in thirty (85.7%) outbreaks and by the media in five (14.3%). The investigation methods used varied. An analytical study was conducted in nine (25.7%) outbreaks and the testing of clinical samples in twenty-seven (77.1%). In three (11.1%) outbreaks, clinical samples were simultaneously tested for multiple bacteria, viruses, and parasites. Water samples were collected in nineteen (54.3%) outbreaks (in three after chlorination) with a mean time lag of 5 days (range: 1–20 days) from the first cases. A pathogen in clinical samples was identified in 20 (57.1%) outbreaks and, in 1 (6.25%), the same microorganism was isolated in both clinical and water samples. Conclusions: delays in reporting and the heterogeneity of investigations depict that the surveillance of WGDOs and response practices should be strengthened, and operational procedures should be standardised.


  • Open Access

    A Community Waterborne Salmonella Bovismorbificans Outbreak in Greece

    by Lida Politi, Kassiani Mellou, Anthi Chrysostomou, Georgia Mandilara, Ioanna Spiliopoulou, Antonia Theofilou, Michalis Polemis, Kyriaki Tryfinopoulou, Theologia Sideroglou

    Background: In August 2022, the Hellenic National Public Health Organisation was notified about a gastroenteritis outbreak in town A in Southern Greece. Investigations aimed to identify the source and implement control measures. Methods: Case definition categories were used in a 1:3 case–control study. Cases and controls were interviewed about various exposures. Cases’ stool samples were cultured on agar plates and characterised by serotyping, antimicrobial susceptibility testing and Pulse Field Gel Electrophoresis (PFGE). Environmental investigations included tap water sampling for microbiological and chemical analysis in town A and inspection of the water supply system. Results: We identified 33 cases (median age: 17 years). Tap water consumption was the only significant risk factor for gastroenteritis (OR = 5.46, 95% CI = 1.02–53.95). Salmonella (S.) Bovismorbificans isolated from eight stool and one tap water samples had identical PFGE profiles. No resistant isolates were identified. Residual chlorine levels were lower than the acceptable limits before and during the outbreak. We advised consumption of bottled water and adherence to strict hand hygiene rules until tap water was declared suitable for drinking. Conclusions: Epidemiological and molecular data revealed a waterborne S. Bovismorbificans outbreak in town A. We recommend local water safety authorities to ensure that residual chlorine levels comply with the legislation towards water safety planning, to mitigate risks.


  • Open Access

    The 2022 West Nile Virus Season in Greece; A Quite Intense Season

    by Danai Pervanidou, Chrysovaladou Niki Kefaloudi, Anna Vakali, Ourania Tsakalidou, Myrsini Karatheodorou, Katerina Tsioka, Maria Evangelidou, Kassiani Mellou, Styliani Pappa, Konstantina Stoikou, et al.

    Since 2010, the West Nile virus (WNV) has been established in Greece. We describe the epidemiology of diagnosed human WNV infections in Greece with a focus on the 2022 season. During the transmission period, clinicians were sending samples from suspected cases for testing. Active laboratory-based surveillance was performed with immediate notification of diagnosed cases. We collected clinical information and interviewed patients on a timely basis to identify their place of exposure. Besides serological and molecular diagnostic methods, next-generation sequencing was also performed. In 2022, 286 cases of WNV infection were diagnosed, including 278 symptomatic cases and 184 (64%) cases with neuroinvasive disease (WNND); 33 patients died. This was the third most intense season concerning the number of WNND cases, following 2018 and 2010. Most (96%) cases were recorded in two regions, in northern and central Greece. The virus strain was a variant of previous years, clustering into the Central European subclade of WNV lineage 2. The 2022 WNV season was quite intense in Greece. The prompt diagnosis and investigation of cases are considered pivotal for the timely response, while the availability of whole genome sequences enables studies on the molecular epidemiology of the disease.


  • Open Access

    Overview of Mpox Outbreak in Greece in 2022–2023: Is It Over?

    by Kassiani Mellou, Kyriaki Tryfinopoulou, Styliani Pappa, Kassiani Gkolfinopoulou, Sofia Papanikou, Georgia Papadopoulou, Evangelia Vassou, Evangelia-Georgia Kostaki, Kalliopi Papadima, Elissavet Mouratidou, et al.

    In May 2022, for the first time, multiple cases of mpox were reported in several non-endemic countries. The first ever case of the disease in Greece was confirmed on 8 June 2022, and a total of 88 cases were reported in the country until the end of April 2023. A multidisciplinary response team was established by the Greek National Public Health Organization (EODY) to monitor and manage the situation. EODY’s emergency response focused on enhanced surveillance, laboratory testing, contact tracing, medical countermeasures, and the education of health care providers and the public. Even though management of cases was considered successful and the risk from the disease was downgraded, sporadic cases continue to occur. Here, we provide epidemiological and laboratory features of the reported cases to depict the course of the disease notification rate. Our results suggest that measures for raising awareness as well as vaccination of high-risk groups of the population should be continued.


  • Open Access

    Overview of Mpox outbreak in Greece in 2022-2023; Is it over?

    by Kassiani Mellou, Kyriaki Tryfinopoulou, Styliani Pappa, Kassiani Gkolfinopoulou, Sofia Papanikou, Georgia Papadopoulou, Evaggelia Vassou, Evaggelia- Georgia Kostaki, Kalliopi Papadima, Elissavet Mouratidou, et al.

    In Μay 2022, for the first time, multiple cases of mpox were reported in several non-endemic countries. The first ever case of the disease in Greece was confirmed on 8 June 2022 and a total of 88 cases were reported in the country until the end of April 2023. A multidisciplinary response team was established by the Greek National Public Health Organization (EODY) to monitor and manage the situation. EODY’s emergency response focused on enhanced surveillance, laboratory testing, contact tracing, medical countermeasures, and education of health care providers and the public. Even though management of cases was considered successful and the risk from the disease was down-graded, sporadic cases continue to occur. Here, we provide epidemiological and laboratory features of the reported cases to depict the course of the disease notification rate, that suggests measures for raising awareness as well as vaccination of high-risk groups of the population should be continued.


  • Open Access

    Wastewater Levels of Respiratory Syncytial Virus Associated with Influenza-like Illness Rates in Children—A Case Study in Larissa, Greece (October 2022–January 2023)

    by Michalis Koureas, Kassiani Mellou, Alexandros Vontas, Maria Kyritsi, Ioannis Panagoulias, Anastasia Koutsolioutsou, Varvara A. Mouchtouri, Matthaios Speletas, Dimitrios Paraskevis, Christos Hadjichristodoulou

    The emergence of the COVID-19 pandemic has led to significant progress in the field of wastewater-based surveillance (WBS) of respiratory pathogens and highlighted its potential for a wider application in public health surveillance. This study aimed to evaluate whether monitoring of respiratory syncytial virus (RSV) in wastewater can provide a comprehensive picture of disease transmission at the community level. The study was conducted in Larissa (Central Greece) between October 2022 and January 2023. Forty-six wastewater samples were collected from the inlet of the wastewater treatment plant of Larissa and analyzed with a real-time reverse transcription polymerase chain reaction (RT-PCR) based method. RSV and SARS-CoV-2 wastewater viral loads (genome copies/100,000 inhabitants) were analyzed against sentinel surveillance data on influenza-like illness (ILI) to identify potential associations. Univariate linear regression analysis revealed that RSV wastewater viral load (lagged by one week) and ILI notification rates in children up to 14 years old were strongly associated (std. Beta: 0.73 (95% CI: 0.31–1.14), p = 0.002, R2 = 0.308). A weaker association was found between SARS-CoV-2 viral load and ILI rates in the 15+ age group (std. Beta: 0.56 (95% CI: 0.06–1.05), p = 0.032, R2 = 0.527). The results support the incorporation of RSV monitoring into existing wastewater-based surveillance systems.


  • Open Access

    COVID-19 Burden in Long-Term Care Facilities in the Omicron Era: Public Health Action Not Yet Redundant

    by Dimitra Krystallaki, Christina-Anna Kavakioti, Maria Gkova, Soultana Sypsa, Kyriaki Tryfinopoulou, Aikaterini Gavrili, Aikaterini Dimitriou, Spyridon Sapounas, Dimitrios Paraskevis, Kassiani Mellou

    Since the beginning of the pandemic, public health authorities have provided support to long-term care facilities (LTCFs) for the implementation of risk mitigation measures. Nevertheless, the necessity of these measures has been doubted, especially after vaccines and antiviral treatment became available. Here, we present the burden of COVID-19 infection in LTCFs during the first 9 months of 2022 across Greece. We tested the possible association of LTCF characteristics and public health response with the occurrence of clusters (two or more linked cases in LTCFs) with facilities recording one case as reference. After excluding LTCFs with sporadic cases, we tested the effect of the abovementioned variables on attack rate (cases/total number of persons in the LTCF). The disease burden in LTCFs was high and substantially varied among facilities, with hospitalization and case fatality rates ranging from 2 to 80% (median 14%, IQR 27%) and from 1 to 50% (median 5%, IQR 7%), respectively. The probability of transmission inside the facility increased when notification of public health authorities was delayed (p-Value < 0.001) after adjusting for vaccination status and phase of the pandemic. Results showed that active support from public health authorities is still important in reducing the burden in LTCFs.